Class I recall: Baxter Healthcare Corporation: 0.9% Sodium Chloride Injection USP 500 mL, VIAFLEX Plastic Containers, with 24 u
Baxter Healthcare Corporation has issued a Class I recall for 0.9% Sodium Chloride Injection USP, 500 mL, in VIAFLEX plastic containers, NDC 0338-0049-03. The recall states the product may contain particulate matter identified as fiberglass. FDA classifies this as a Class I recall, indicating the most serious recall category.
Most relevant for: Clinical settings that stock or administer this specific lot of Baxter 0.9% Sodium Chloride Injection USP in 500 mL VIAFLEX containers for intravenous use.
Read the original at FDA Drug Enforcement ReportsSummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
More internal medicine updates
- Long-acting injectable noninferior to oral HIV therapy in adherence trialOct 15, 2026
- Ponatinib-Blinatumomab Beats Imatinib-Chemotherapy in Ph-Positive ALL TrialOct 15, 2026
- Isoflurane sedation does not lower mortality in hypoxemic respiratory failureOct 14, 2026
- Trial finds higher mortality with intermittent vs continuous renal-replacement therapyOct 14, 2026
- No Overall Rise in Birth Defects With Early Benzodiazepine UseOct 13, 2026